Previous Close | 121.27 |
Open | 121.00 |
Bid | 103.00 |
Ask | 110.90 |
Strike | 420.00 |
Expire Date | 2026-01-16 |
Day's Range | 121.00 - 122.90 |
Contract Range | N/A |
Volume | |
Open Interest | 17 |
ELV vs. GDRX: Which Stock Is the Better Value Option?
The sale of KR's specialty pharmacy to Elevance Health enables the company to focus on core strengths while enhancing patient care and supporting growth.
INDIANAPOLIS, October 07, 2024--Elevance Health (NYSE: ELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: